Skip to main content

Advertisement

SpringerLink
Log in

The role of Tα1 on the infective patients after hematopoietic stem cell transplantation

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The present study was designed to investigate the effect of thymosin α1 (Tα1) administration in infective recipients of hematopoietic stem cell transplantation (HSCT) for hematologic malignancies. Eight patients were enrolled in our study, including seven allo-HSCT patients and one auto-HSCT patient. These patients were allocated randomly into the treatment group (four cases) and control group (four cases). Tα1 was used in the treatment group to test its effectiveness in infection control. The concentrations of cytokines IFN-γ, IL-2, IL-4, IL-10, and IL-12 were observed, and the levels of CD3+, CD4+, and CD8+ T cells, as well as of CD4+/CD8+ and CD4+/CD25+ regulatory T cell (Treg) were measured. When Tα1 was administered for 2 weeks, the concentrations of these cytokines were increased after 1 month in the treatment group. Interestingly, the levels of IFN-γ, IL-2, IL-10, and IL-12 were increased in the treatment group more than those in the control group, whereas there were no significant differences between the treatment and control group in the levels of CD3+, CD4+, and CD8+ T cells, or in CD4+/CD8+ or CD4+/CD25+ Treg cells. Notably, Tα1 administration did not cause acute or chronic graft versus host disease (GVHD). We conclude that Tα1 administration is safe and may impact favorably on immune function, and that it may improve resistance to infection and induce immunotolerance without GVHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Dazzi F, Fozza C. Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment. Best Pract Res Clin Haematol. 2007;20(2):311–27.

    Article  PubMed  CAS  Google Scholar 

  2. Romani L, Bistoni F, Montagnoli C, Gaziano R, Bozza S, Bonifazi P, et al. Thymosin alpha 1—an endogenous regulator of inflammation, immunity, and tolerance. Thymosin Health Dis First Int Symp. 2007;1112:326–38.

    CAS  Google Scholar 

  3. Sorensen RB, Hadrup SR, Svane IM, Hjortso MC, Straten PT, Andersen MH. Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators. Blood. 2011;117(7):2200–10.

    Article  PubMed  Google Scholar 

  4. Orabona C, Puccetti P, Vacca C, Bicciato S, Luchini A, Fallarino F, et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood. 2006;107(7):2846–54.

    Article  PubMed  CAS  Google Scholar 

  5. Andersen MH. The specific targeting of immune regulation: T-cell responses against indoleamine 2,3-dioxygenase. Cancer Immunol Immunother. 2012;61(8):1289–97.

    Article  PubMed  CAS  Google Scholar 

  6. Perruccio K, Bonifazi P, Topini F, Tosti A, Bozza S, Aloisi T, et al. Thymosin α1 to harness immunity to pathogens after haploidentical hematopoietic transplantation. Ann N Y Acad Sci. 2010;1194:153–61.

    Article  PubMed  CAS  Google Scholar 

  7. Romani L, Bistoni F, Perruccio K, Montagnoli C, Gaziano R, Bozza S, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood. 2006;108(7):2265–74.

    Article  PubMed  CAS  Google Scholar 

  8. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4(+)CD25(+) regulatory T cells. J Immunol. 2004;173(7):4433–42.

    PubMed  CAS  Google Scholar 

  9. Aversa FA, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23(15):3447–54.

    Article  PubMed  Google Scholar 

  10. Chiesa R, Veys P. Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies. Expert Rev Clin Immunol. 2012;8(3):255–66.

    Article  PubMed  CAS  Google Scholar 

  11. Romani L, Bistoni F, Gaziano R, Bozza S, Montagnoli C, Perruccio K, et al. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood. 2004;103(11):4232–9.

    Article  PubMed  CAS  Google Scholar 

  12. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 2003;24(5):242–8.

    Article  PubMed  CAS  Google Scholar 

  13. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112(11):1688–96.

    PubMed  CAS  Google Scholar 

  14. Yong Z, Chang L, Mei YX, Yi L. Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance. Transpl Immunol. 2007;17(2):120–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Funding for this work was provided by Key Department of Jiangsu Medicine (2011–12).

Author information

Authors and Affiliations

  1. Department of Hematology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China

    Jia-Hua Ding, Lin-Lin Wang, Zhi Chen, Jun Wang, Zheng-Ping Yu, Gang Zhao & Bao-An Chen

Authors
  1. Jia-Hua Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lin-Lin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zheng-Ping Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bao-An Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bao-An Chen.

About this article

Cite this article

Ding, JH., Wang, LL., Chen, Z. et al. The role of Tα1 on the infective patients after hematopoietic stem cell transplantation. Int J Hematol 97, 280–283 (2013). https://doi.org/10.1007/s12185-012-1208-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1208-5

Keywords

Search

Navigation